Flamel might be earning more than had been calculated from its lead drug, but the company still isn't profitable. Flamel gets royalties from sales of heart-disease drug Coreg CR, which it helped ...

Stocks fall when study fails to show drug's superiority. There's no sector more volatile than the pharma sector as Flamel Technologies (NASDAQ:FLML) has proven in the past three months. Shares of the ...

To earn CME related to this news article, click here. March 11, 2009 — The US Food and Drug Administration (FDA) has approved safety labeling revisions to warn against use of anastrozole in pregnancy ...

Flamel Receives FDA Response Letter Regarding Coreg CR Citizen’s Petition LYON, France--(BUSINESS WIRE)-- Flamel Technologies (Nasdaq: FLML) announced today that it has achieved a clinical development ...

FDA sanctions generic versions of Coreg in all strengths. FDA issued approval for 14 companies to manufacture and sell the first generic versions of GlaxoSmithKline’s (GSK) cardiovascular medication ...

BRIDGEWATER, N.J., Dec. 8, 2017 /PRNewswire/ -- Impax Laboratories, Inc. (NASDAQ: IPXL), a specialty pharmaceutical company, today announced it has received tentative U.S. Food and Drug Administration ...

As we begin the final month of 2006, now is a good time to survey the landscape in nanobiotech and see what investors can look forward to in 2007. Click here to download "How Nanotech Will Save You ...

BOSTON -- Carvedilol (Coreg, Coreg CR) helped to mitigate cardiac risk in patients undergoing pheochromocytoma surgery, researchers reported here. In a comparison of several blood pressure (BP) ...

The first generic versions of GlaxoSmithKline’s cardiovascular agent Coreg – all 14 of them – have been approved by US regulators. The first generic versions of GlaxoSmithKline’s cardiovascular agent ...

Philadelphia, PA - The US Food and Drug Administration has approved a once-daily form of the beta blocker carvedilol (Coreg CR) for the treatment of patients with hypertension, postinfarction LV ...